ROMANO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 6.989
EU - Europa 3.996
AS - Asia 3.745
Continente sconosciuto - Info sul continente non disponibili 424
SA - Sud America 381
AF - Africa 86
OC - Oceania 12
AN - Antartide 1
Totale 15.634
Nazione #
US - Stati Uniti d'America 6.733
SG - Singapore 1.441
CN - Cina 928
IT - Italia 874
IE - Irlanda 474
UA - Ucraina 460
GB - Regno Unito 444
RU - Federazione Russa 398
SE - Svezia 396
TR - Turchia 364
FR - Francia 327
VN - Vietnam 317
BR - Brasile 278
IN - India 275
DE - Germania 243
FI - Finlandia 129
CA - Canada 116
BD - Bangladesh 102
HK - Hong Kong 89
PL - Polonia 66
KR - Corea 44
AT - Austria 43
MX - Messico 39
JP - Giappone 37
AR - Argentina 36
NL - Olanda 30
ES - Italia 28
ZA - Sudafrica 28
IL - Israele 19
PE - Perù 19
IQ - Iraq 18
EG - Egitto 17
BE - Belgio 16
LT - Lituania 15
PK - Pakistan 15
CZ - Repubblica Ceca 14
PH - Filippine 14
IR - Iran 13
SC - Seychelles 12
CR - Costa Rica 11
EU - Europa 11
GT - Guatemala 11
HN - Honduras 11
VE - Venezuela 11
BZ - Belize 10
CL - Cile 10
ID - Indonesia 10
JM - Giamaica 10
KE - Kenya 10
SV - El Salvador 10
UZ - Uzbekistan 10
AU - Australia 9
CO - Colombia 9
MA - Marocco 9
TT - Trinidad e Tobago 9
EC - Ecuador 8
PR - Porto Rico 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 6
NI - Nicaragua 6
PT - Portogallo 5
RO - Romania 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
EE - Estonia 4
GP - Guadalupe 4
OM - Oman 4
PY - Paraguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
BS - Bahamas 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
AM - Armenia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GR - Grecia 2
JO - Giordania 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BH - Bahrain 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
GF - Guiana Francese 1
Totale 15.213
Città #
Singapore 1.075
San Jose 790
Chandler 666
Jacksonville 520
Dublin 468
Ashburn 412
Dallas 294
Southend 268
Council Bluffs 233
Beijing 229
Princeton 207
Izmir 202
New York 181
Santa Clara 157
Los Angeles 151
Nanjing 132
Dearborn 112
The Dalles 110
Boardman 108
Chieti 104
Ho Chi Minh City 94
Altamura 90
Wilmington 88
Cambridge 80
Buffalo 79
Ann Arbor 73
Hanoi 73
North Bergen 72
Hong Kong 71
Tongling 66
Nanchang 63
Rome 58
Pescara 55
Moscow 45
Warsaw 45
Phoenix 44
Houston 38
Montreal 38
Helsinki 37
Seoul 37
São Paulo 35
Montesilvano 34
Tokyo 34
Vienna 34
Washington 34
Brooklyn 32
Denver 31
Milan 30
Munich 30
Toronto 30
San Mateo 29
Chicago 27
Woodbridge 25
Hebei 24
Orem 24
Tianjin 24
Kunming 23
Redondo Beach 23
Dong Ket 22
Johannesburg 22
Shenyang 22
Atlanta 21
Columbus 21
Düsseldorf 21
Jiaxing 21
Falls Church 20
Frankfurt am Main 20
Nuremberg 20
Stockholm 20
Augusta 19
Boston 19
San Francisco 19
Hefei 18
Poplar 18
St Louis 18
Haiphong 16
London 16
Mexico City 16
Seattle 16
Brussels 15
Chennai 15
Cornaredo 14
Da Nang 14
Grevenbroich 14
Changsha 13
Cairo 12
Central 12
Manchester 12
New Delhi 12
Amsterdam 11
Bari 11
Mumbai 11
Turku 11
Brasília 10
Ica 10
Nairobi 10
Orange 10
Philadelphia 10
Querétaro 10
San Buono 10
Totale 8.840
Nome #
Sistema di rilascio della lipossina A4 mediante membrana polimerica porosa ottenuta con elettrofilatura 402
Impiego di cellule staminali da legamento parodontale per lo screening farmacologico in fibrosi cistica. 241
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 226
Establishment and long-term culture of human cystic fibrosis endothelial cells 218
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 215
Molecular and phenotypic characterization of human amniotic fluid-derived cells: A morphological and proteomic approach 210
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 206
Wnt Signaling Behaves as a "Master Regulator" in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells 206
ASSOCIATION OF LEPTIN, ENDOTHELIAL PERTURBATION AND COAGULATIVE ACTIVATION IN OBESE HEALTHY WOMEN (XVI National Congress of the Italian Society for the study of Arteriosclerosis - Chieti, 27-30 novembre 2002) 201
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 201
Mechanisms of endothelial cell dysfunction in cystic fibrosis 199
Pentraxin 3 and platelet activation in obese patients after gastric banding 192
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 183
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 180
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 179
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 178
Microvascular and Macrovascular Endothelial Cell Isolation and Purification from Lung-Derived Samples 176
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 176
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 175
Immobilization and delivery of biologically active Lipoxin A4 using electrospinning technology 172
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction 171
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics 170
Screening tool for anti-inflammatory drug discovery comprising the FPR2/ALX gene promoter 170
Increased soluble CD40L levels in cystic fibrosis 164
5-Lipoxygenase regulates malignant mesothelial cellsurvival: involvement of vascular endothelialgrowth factor 164
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 163
Lipoxins, resolvins, and the resolution of inflammation 163
Activation of human monocytes and the acute monocytic cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 and lipoxin B4: evidence for differential Ca2+ mobilization 161
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 161
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels 159
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 156
Epigenetic regulation of the formyl peptide receptor 2 gene 156
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 156
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 156
Association of Inflammation Markers with ImpairedInsulin Sensitivity and Coagulative Activation inObese Healthy Women 155
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 154
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 151
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 151
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 151
Physical exercise increases urinary excretion of lipoxin A4 and related compounds 148
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 148
Leptin increase is associated with markers of the hemostatic system in obese healthy women 147
A Systematic Review on Organ-on-a-Chip in PDMS or Hydrogel in Dentistry: An Update of the Literature 145
Lipoxin receptors 144
Diabetes mellitus during pregnancy interferes with the biological characteristics of wharton's jelly mesenchymal stem cells 144
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen 144
Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins 143
Endothelial Perturbation in Children andAdolescents With Type 1 Diabetes: association with markers of the inflammatory reaction 143
Homocysteine modulates the CD40/CD40L system 142
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 142
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 142
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 141
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 140
Increased levels of soluble P-selectin in hypercholesterolemic patients 138
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 137
Lipoxin and aspirin-triggered lipoxins 135
Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells 133
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 130
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 128
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 127
Transcellular regulation of eicosanoids biosyntesis 125
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 125
5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 125
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders 123
Cyclooxygenase-2-derived lipoxin A(4) increases gastric resistance to aspirin-induced damage 122
G972R IRS-1 variant impairs insulin regulation of eNOS in cultured human endothelial cells 122
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 122
Induction of functional Lipoxin A4 receptors in HL-60 cells 121
Hepatocytes are a rich source of novel aspirin-trigged 15-epi-lipoxin A(4) 119
Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study 118
Methionine aminopeptidase-2 regulates human mesothelioma cell survival - Role of bcl-2 expression and telomerase activity 118
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 117
Ligand bias and its association with pro-resolving actions of melanocortin drugs 117
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R 116
Human alveolar macrophages generate 15-HETE and can produce lipoxins 115
Peptido-leukotrienes stimulate von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells 115
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 115
The Resolution Approach to Cystic Fibrosis Inflammation 115
Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: Implications for cancer therapy 113
Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins 113
Lipoxin biosynthesis and actions: role of the human platelet LX-Synthase 112
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin 112
Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip 112
Lipoxin generation by human magakaryocyte-induced 12-lipoxygenase 111
Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity? 110
Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer 109
Lipoxin synthase activity of human platelet 12-Lipoxygenase 108
Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study 108
Interaction of endotoxic lipid A and lipid X with purified human platelet protein kinase C 107
Inflammation resolution: does the bone marrow have a say? 107
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 107
Reduced platelet mitogenic activity in myeloproliferative disorders 104
Myelofibrosis: A role for Platelet Derived Growth Factor (PDGF) ? 104
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 102
Lipoxin generation by permeabilized human platelets 101
Loss of CFTR Reverses Senescence Hallmarks in SARS-CoV-2 Infected Bronchial Epithelial Cells 99
Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils 99
Fluticasone propionate reduces serum interleukin 8 in asthmatic patients 98
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis 98
Endothelial perturbation in cystic fibrosis. 97
Totale 14.590
Categoria #
all - tutte 62.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 0 0 0 26 16 10 39 38 39 81 179
2022/20231.804 130 246 111 213 183 327 86 144 234 26 50 54
2023/20241.011 78 46 49 30 57 294 185 51 19 46 22 134
2024/20252.229 130 381 319 83 81 97 78 118 246 92 267 337
2025/20264.598 321 211 461 560 462 265 763 283 453 413 254 152
2026/20271.538 78 237 316 675 232 0 0 0 0 0 0 0
Totale 15.634